Nuvation Bio Is A Global Biopharmaceutical Company Focused On Developing Innovative Oncology Medicinesfounded In 2018 By Drdavid Hungthe Company Aims To Improve Patient Outcomes By Addressing Drug Resistance And Enhancing The Effectiveness Of Existing Therapies While Minimizing Side Effectsnuvation Bio Is Committed To Precision Medicine And Targeted Drug Developmentwith A Strong Emphasis On Scientific Innovation And Patient Centric Approaches The Company S Portfolio Includes Several Therapeutic Candidatessuch As Taletrectinib For Ros1 Positive Cancerssafusidenib For Cancers With Idh1 Mutationsnuv 1511 Targeting Dna Damage Response Pathwaysand Nuv 868 Aimed At Bet Proteins Involved In Cancer Cell Proliferationnuvation Bio Operates Offices In New Yorksan Franciscobostonand Shanghaishowcasing Its Global Presence In The Fight Against Cancerthe Company Is Publicly Traded On The New York Stock Exchange Under The Ticker Symbol Nuvb
No conferences found for this company.
| Company Name | Nuvation Bio Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
